Digestive Health Products for People

Gut health is a trending topic in the human health industry, but it’s a field that Kemin has been studying for decades. Supported by clinical studies showcasing dual benefits for immune and gastrointestinal (GI) health, BetaVia™ serves as a postbiotic. It aids in maintaining a robust immune system and a healthy respiratory tract while promoting digestive health. Additionally, BetaVia offers potential protection against oxidative stress, further enhancing its role in overall health support.

Proven Immunity-Boosting Results

In a 90-day double-blind, placebo-controlled study3, BetaVia demonstrated effectiveness in reducing the likelihood and severity of upper respiratory tract infection (URTI) symptoms, yielding significant results compared to the placebo group. Participants experienced 70% fewer URTI symptoms, with a 3.3-day decrease in sick days and 10 fewer days with URTI symptoms during the trial period.

Fewer Symptoms
Fewer Symptoms
Decrease in Sick Days
Fewer days with Symptoms

Advanced Intestinal and Digestive Health Research

Our research and development team is dedicated to pioneering new solutions that address the evolving challenges in nutrition, health and sustainability, ensuring Kemin remains at the forefront of the intestinal health and digestive health industries.  Check out these other Kemin products focused on your gut health:



Ready to learn more about digestive health solutions?

Fill out the form below to connect with a Kemin expert.


 BetaVita Resources

These statements have not been evaluated by the US Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

The information on this webpage is a business-to-business information and not intended for the final consumer. Certain statements may not be applicable in all geographical regions. Product labeling and associated claims differs based upon government requirements and country or region specific information should also be considered when labeling or advertising to final consumers.

This web page and its associated brochures and other documents do not constitute or provide scientific or medical advice, diagnosis, or treatment and are distributed without warranty of any kind, either expressly or implied. This web page, its title or contents and associated brochures and other documents do not in any way make recommendations for health or marketing claims by the reader. Country and region specific regulations should beconsidered in this regard. Each claim or statement about the effectiveness of Kemin products and/or each claim or statement comparing the effectiveness of Kemin products to the effectiveness of other products is expressly limited to the United States, unless otherwise disclosed on the Kemin websites.

References

1. Euglena gracilis ATCC PTA-123017

2. Salminen, et al. Nat rev Gastroenterol Hepatol (2022). https://www.nature.com/articles/s41575-021-00440-6

3. Evans, M., et al., Effect of a Euglena gracilis Fermentate on Immune Function in Healthy, Active Adults: A Randomized, Double-Blind, Placebo-Controlled Trial. Nutrients, 2019, 11(12), 2926

4. Kemin, BetaVia Complete can prime key cells in the innate immune system. KHTL-017-150.

5. KHTL-017-162 BetaVia Pure Can Prime Key Cell sin the Innate Immune system. KHTL-017-150.

6. KHTL-017-160 Paramylon Improves Antioxidant Status and Metabolic Health-TL-20-18529

7. KHTL-017-149 Characteristics and Prebiotic like Properties of BetaVia Complete

8. Kemin, Characteristics and prebiotic like properties of BetaVia Complete. KHTL-017-149.

9. Bhattad T, Koradiya A, Prakash G. Prebiotic activity of paramylon isolated from heterotrophically grown Euglena gracilis. Heliyon. 2022 Aug 27;7 (9): e07884. doi: 10.1016/j.heliyon.2022.e07884

10. Russo, R., et al. “Euglena gracilis paramylon activates human lymphocytes by upregulating pro-inflammatory factors.” Food Science & Nutrition 5.2 (2017): 205-214

11. Kondo, Y., et al. "Cytokine-related immunopotentiating activities of Paramylon, a β-(1→ 3)-D-glucan from Euglena gracilis." Journal of Pharmacobio-dynamics 15.11 (1992): 617-621.

12. Kankkunen, P., et al. "(1, 3)-β-Glucans activate both dectin-1 and NLRP3 inflammasome in human macrophages." The Journal of Immunology 184.11 (2010): 6335-6342

13. Brown, G.D., and Siamon G. Immune recognition: A new receptor for [beta]-glucans." Nature 413.6851 (2001): 36.

14. Brown, G.D., et al. "Dectin-1 is a major β-glucan receptor on macrophages. Journal of Experimental Medicine 196.3 (2002): 407-412.

15. Brown, G.D., et al. Dectin-1 mediates the biological effects of β-glucans." Journal of Experimental medicine 197.9 (2003): 1119-1124.

16. Goodridge, H.S. et al. "β‐glucan recognition by the innate immune system. Immunological reviews 230.1 (2009): 38-50.

17. KEMIN internal document: SD-18-00083

18. Ishibashi, Ken-ichi, et al. “Effects of Euglena gracilis EOD-1 ingestion on salivary IgA reactivity and health-related quality of life in humans.” Nutrients 11.5 (2019): 1144.

19. Nakashima, Ayaka, et al. “The alga Euglena gracilis stimulates Faecalibacterium in the gut and contributes to increased defecation.” Scientific reports 11.1 (2021): 1-8.

20. Nakashima, Ayaka, et al. “Effects of Euglena gracilis Intake on Mood and Autonomic Activity under Mental Workload, and Subjective Sleep Quality: A Randomized, Double-Blind, Placebo-Controlled Trial.” Nutrients 12.11 (2020): 3243.

21. Kawano, Takanori, et al. “Effect of Food Containing Paramylon Derived from Euglena gracilis EOD-1 on Fatigue in Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trail.” Nutrients 12.10 (2020): 3098.

22. SD-17-00243 Kemin Internal Document (Effect of 50%BG on the immune and intestinal health status of weaned piglets)

23. SD-9-21271 Kemin Internal Document (Effect of 50% BG on IgA in piglet feces)

24. TD-17-0322 Kemin Internal Document (Effect of 50% and 95% BG on gut and systemic immunity in mice)

25. KHTL-017-159 BetaVia Complete Supports Gut Health after Induced Colitis in Mice

26. Kemin Proprietary Data TD-20-6867

27. Vighi, G., Marcucci, F., Sensi, L., Di Cara, G., & Frati, F. (2008). Allergy and the gastrointestinal system. Clinical and experimental immunology, 153 Suppl 1(Suppl 1), 3–6. https://doi.org/10.1111/j.1365-2249.2008.03713.x

28. Patents granted a patent on beta 1,3 glucans for modulating immune function (US Patent 10,912,794). This new patent joins a previously issued patent, US 9574217,on the production of immune modulation using algae from a proprietary strain of Euglena gracilis ATCC PTA-123017.

29. KHTLA-017-181 BetaViaTM helps to Maintain Health and Promote Gut Health by Supporting Intestinal Barrier Integrity

30. KHTLA-017-180 BetaViaTM A Natural New-Generation Postbiotic that works as both an Immune Gut Health Promoter

31. KHTLA-017-148 (TL-20-18591) Characteristics and Prebiotic like properties of BetaVia Complete